Identification of treatment-experienced hepatitis C patients with poor cost-effectiveness of pegylated interferon plus ribavirin from a real-world cohort-Reference-Cited by-同舟云学术

Identification of treatment-experienced hepatitis C patients with poor cost-effectiveness of pegylated interferon plus ribavirin from a real-world cohort

Published:2018-01 Issue:1 Volume:117 Page:54-62
ISSN:0929-6646
Container-title:Journal of the Formosan Medical Association
language:en
Short-container-title:Journal of the Formosan Medical Association

Author:

Liu Ta-Wei,Tsai Pei-Chien,Huang Ching-I,Tsai Yi-Shan,Wang Shu-Chi,Ko Yu-Min,Lin Ching-Chih,Chen Kuan-Yu,Liang Po-Cheng,Lin Yi-Hung,Hsieh Ming-Yen,Hou Nai-Jen,Huang Chung-Feng,Yeh Ming-Lun,Lin Zu-Yau,Chen Shinn-Cherng,Dai Chia-Yen,Chuang Wan-Long,Huang Jee-Fu,Yu Ming-Lung^ORCID

Publisher

Elsevier BV

Subject

General Medicine

Reference43 articles.

1. Global epidemiology and genotype distribution of the hepatitis C virus infection;Gower;J Hepatol,2014

2. Global distribution and prevalence of hepatitis C virus genotypes;Messina;Hepatology,2015

3. Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence;Mohd Hanafiah;Hepatology,2013

4. Aging of hepatitis C virus (HCV)-infected persons in the United States: a multiple cohort model of HCV prevalence and disease progression;Davis;Gastroenterology,2010

5. Natural history of hepatitis C;Westbrook;J Hepat,2014

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characteristics of patients with hepatitis C virus infection and antiviral treatment initiation in Taiwan: The MOSAIC study;The Kaohsiung Journal of Medical Sciences;2020-10-22

2. A real world cost effectiveness analysis of interferon-based therapy for HCV naïve super-responders;Journal of the Chinese Medical Association;2018-08

3. Highlights;Journal of the Formosan Medical Association;2018-01